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Plasma membrane expressionRecent evidences show that the localization of different plasmamembrane Ca2+ATPases (PMCAs) is regulated in
various complex, cell type-speciﬁc ways. Here we show that in low-density epithelial and endothelial cells
PMCA4b localized mostly in intracellular compartments and its plasma membrane localization was enhanced
upon increasing density of cells. In good correlation with the enhanced plasma membrane localization a signif-
icantlymore efﬁcient Ca2+ clearancewas observed in conﬂuent versus non-conﬂuentHeLa cell cultures express-
ing mCherry-PMCA4b. We analyzed the subcellular localization and function of various C-terminally truncated
PMCA4b variants and found that a truncated mutant PMCA4b-ct24 was mostly intracellular while another mu-
tant, PMCA4b-ct48, localizedmore to the plasmamembrane, indicating that a protein sequence corresponding to
amino acid residues 1158–1181 contained a signal responsible for the intracellular retention of PMCA4b in
non-conﬂuent cultures. Alteration of three leucines to alanines at positions 1167–1169 resulted in enhanced
cell surface expression and an appropriate Ca2+ transport activity of both wild type and truncated pumps,
suggesting that the di-leucine-like motif 1167LLL was crucial in targeting PMCA4b. Furthermore, upon loss of
cell–cell contact by extracellular Ca2+ removal, the wild-type pump was translocated to the early endosomal
compartment. Targeting PMCA4b to early endosomeswas diminished by the L1167–69Amutation, and themutant
pump accumulated in long tubular cytosolic structures. In summary, we report a di-leucine-like internalization
signal at the C-tail of PMCA4b and suggest an internalization-mediated loss of function of the pump upon low
degree of cell–cell contact.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The Ca2+ signal is ﬁnely tuned by concerted actions of channels
(that switch on the Ca2+ signal) and pumps (that switch it off) located
in intracellular compartments as well as in the plasma membrane [1].
Both switch mechanisms are tightly controlled in space and time to
meet speciﬁc needs of the cells. One of the main “off” mechanisms of
the Ca2+ signal is the plasma membrane Ca2+ ATPase (PMCA) present
in all kinds of cells [2,3]. Four separate genes code for PMCA isoforms
1–4 and alternative splicing of the primary transcripts further increases
the number of PMCA variants to over 20 [4,5]. The PMCA isoforms differ
signiﬁcantly in their regulatory and kinetic properties [3,6]. Therefore,
they have the ability to control different cellular functions [7]. Activity
of PMCAs is achieved at 3 levels (1) PMCAs can be regulated at thendoplasmic reticulum; MDCK,
M, plasma membrane; PMCA,
SERCA, sarco/endoplasmic re-
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rights reserved.transcriptional level [8]. Moreover, inﬂuencing the transcription of cer-
tain types of PMCAs can generate complex changes in the expression of
other PMCAs and Ca2+ signaling systems [9]. (2) The second level of
PMCA activity regulation is post-transcriptionalmodiﬁcation of the pro-
tein by calmodulin-binding, phosphorylation and/or proteolysis [10].
(3) The third level of activity control is changing the subcellular locali-
zation of PMCA. Adjusting the density of PMCA in particular plasma
membrane compartments substantially contributes to the speciﬁc out-
come of the Ca2+ signal. Recent experiments from our laboratory and
others suggested that the “w” splice is essentially important in the api-
cal localization of the PMCA2w isoform in polarized MDCK cells [11,12]
or in the stereocilia of hair cells [13]. Our experiments also showed
that co-expression with the Na+/H+ exchanger regulatory factor 2
(NHERF2) greatly enhanced the apical localization of PMCA2w/b [14]
the prominent pump of the lactating mammary gland [15]. NHERF2
was also required for the agonist-induced plasmamembrane transloca-
tion of PMCA in HT-29 human colonic epithelial cells [16].
PMCA4b has the lowest basal activity and the slowest activation
rate of all PMCAs [6]. This is the pump of cells derived from hemato-
poietic stem cells and in cells of epithelial origin; thus it is expressed
mostly in non-excitable cells/tissues where it can handle relatively
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pression of the PMCA4b isoform is increased during differentiation
of cells [17,18]. These studies demonstrated upregulation of PMCA4
expression during conﬂuence-mediated differentiation of colon-cancer
cells. Changes in the localization pattern of the PMCA4 protein in
post-conﬂuent cultures in colon cancer cells [19] as well as in mouse
distal convoluted tubule (mDCT) cells [20] have also been reported.
Previously, we described enhanced plasma membrane localization of
the PMCA4b pump in COS-7 and N2a cells elicited by a C-terminal PDZ
interaction between the pump and the post synaptic density protein,
PSD-95 [21]. Speciﬁc localization of PMCA4 was further established in
cholesterol-rich lipid rafts in synaptosomes of pig cerebellum [22] and
at the immunological synapse together with the ORAI channels and
mitochondria [23].
An important way to inﬂuence cell signaling is the endocytic regula-
tion of signaling proteins residing in the plasma membrane (receptors,
channels and transporters) [24,25]. The proteins can be internalized
either by clathrin-dependent or clathrin-independent pathways [26].
The internalization of proteins to endosomes is usually mediated by spe-
ciﬁc short sequence signal motifs including tyrosine-based sequences,
dileucine-based motifs and single amino acid-speciﬁc sequences [27].
Di-leucine-based motifs are known to play role in the endocytosis and
trafﬁcking of various membrane receptors and proteins [28–33] (for a
review, see [34]).
Little is known about the molecular mechanisms underlying the
regulation of surface expression of the PMCAs, especially that of the
PMCA4b isoform. Early localization studies using the ﬁbroblast COS-7
cell line and C-terminal truncations/site-directed mutagenesis described
an ER retention signal right upstream of the calmodulin-binding se-
quence between residues Glu1067 and Arg1087 of the PMCA4b pump
[35]. This study described that removal of the C-terminal 118 residues
resulted in exposing the retention signal so that the PMCA4bΔ118 mutant
retained in the ER compartment. Laterwe found that a C-terminally trun-
cated PMCA4b-ct125mutant localized correctly to the plasmamembrane
of fully polarized MDCK cells [36].
Here we show that increasing conﬂuence of HeLa and HUVEC cells
enhances plasma membrane localization of both the transiently and
endogenously expressed PMCA4b pump. Detailed localization studies
of C-terminally truncated mutant PMCA4b pumps uncovered a novel
putative di-leucine-like motif downstream of the calmodulin-binding
sequence. Further, we show that internalization of this pump upon
low Ca2+ mediated loss of cell–cell contact occurs through the
endosomal system that possibly uses the pathway of cadherins in
HeLa cells.
2. Materials and methods
2.1. Chemicals and reagents
FuGene HD Transfection Reagent was obtained from Roche Ap-
plied Science. DMEM and OPTI-MEM were purchased from Gibco.
LipofectAMINE was obtained from Invitrogen. Pierce Cell Surface
Protein Isolation Kit (Prod. No. 89881) was obtained from Thermo
Scientiﬁc. Pan-PMCA-speciﬁc mouse monoclonal antibody 5F10
[37] was used at a dilution of 1:5000 for immunoblotting and 1:250
for indirect immunoﬂuorescence staining. PMCA4-speciﬁc mouse
monoclonal antibody JA9 and PMCA4b-speciﬁc mouse monoclonal
antibody JA3 were used at a dilution of 1:100 [37] . IgG1 isotype control
antibody (Sigma-Aldrich) was used at dilution 1:100. Chicken polyclonal
anti-Sodium Potassium ATPase (Abcam) and anti-pan-cadherin (Abcam)
antibodieswere used at a dilution of 1:250 for imunoﬂuorescence stain-
ing. Anti-EEA1 (Abcam) was used at a dilution of 1:500. Wheat germ
agglutinin (WGA) Alexa Fluor 633 conjugate (Molecular Probes),
Alexa Fluor 488- and 594-conjugated goat anti-mouse IgG (Molecular
Probes), Alexa Fluor 594-conjugated goat anti-rabbit IgG (Molecular
Probes) andAlexa Fluor 647-conjugated goat anti-chicken IgG (MolecularProbes) antibodies were purchased from Invitrogen Corp. All other
chemicals used were of reagent grade.
2.2. Construction of expression vectors
The truncated mutants (PMCA4b-ct24, -ct48, -ct57) have been
previously generated by polymerase chain reaction and have been
inserted into the expression plasmid pMM2 [37–39]. Suitable muta-
tions were generated by site-directed mutagenesis using the overlap
extension technique [40] utilizing the pMM2–PMCA4b [41] or the
pMM2–PMCA4b-ct24 plasmids as a template. For each mutation,
two separate DNA fragments having overlapping ends were ampli-
ﬁed. Complementary internal primers used for the L1167–69A mutation
were: forward 5′-CTAGGGTGGCAGCGGCGGATGGTG-3′ and reverse
5′-CACCATCCGCCGCTGCCACCCTAG-3′, internal primers used for the
L1147–48A mutation were: forward 5′-CACCAGCCGCGGATGAGGAA-3′
and reverse 5′-TTCCTCATCCGCGGCTGGTG-3′, external primers for
each mutation were: forward 5′-CTTCAATGAAATCAACTCCCG-3′ and
reverse 5′-CGTCTCAGGTACACCGAGC-3′. The overlapping fragments
containing the mutations were fused together in a subsequent exten-
sion reaction. The full-length constructs were ligated at the BbvCI-HpaI
sites of the pMM2–PMCA4b or the pMM2–PMCA4b-ct24 plasmids. To
create pEGFP–PMCA4b-L1167–69A construct, themutation containing in-
sertwas cut out from the pMM2plasmidwith the PﬂMI andKpnI restric-
tion enzymes and the insert was ligated into the PﬂMI–KpnI sites of the
pEGFP–PMCA4b template plasmid [12]. To make the mCherry-PMCA4b
construct, BamHI andXhoI restriction siteswere added to the ends of the
mCherry sequence taken from a pcDNA3-mCherry plasmid (kind gift
from Robert Katona, Institute of Genetics, Biological Research Center of
the Hungarian Academy of Sciences) by performing PCR with the
following primers: forward 5′-CGAGCTCGGATCCACCATGGTGAGC-3′,
reverse 5′-GCTCTCGAGTGCTTGTACAGCTCGTCC-3′. In this way the
stop codon from the mCherry sequence was removed and a XhoI re-
striction site was added to it. This mCherry sequence was cloned into
the pcDNA3.0 vector thus creating a new pcDNA3.0-mCherry vector
containing a XhoI restriction site. The PMCA4b coding fragment was
cut from the pEGFP–PMCA4b plasmid with XhoI and ligated into the
XhoI site of the pcDNA3.0-mCherry vector. pN1-GCaMP2 plasmid
was a kind gift of Junichi Nakai, RIKEN Brain Science Institute, Saitama,
Japan [42].
2.3. Cell culture, transfection and Western blotting
HUVEC cells were kindly provided by the Institute of Pathophysi-
ology, Semmelweis University, Budapest, Hungary. Cells were freshly
isolated from human umbilical cord veins as described [43,44]. Cells
from passages 2–4 were used for experiments. HeLa, MDCKII and
COS-7 cells were cultured in Dulbecco's modiﬁed Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum, 2 mM L-gluta-
mine, 100 units/ml penicillin and 100 μg/ml streptomycin at 37 °C
in a humidiﬁed atmosphere containing 5% CO2. Cells were transfected
with the appropriate DNA constructs using the FuGENE HD (Roche)
or LipofectAMINE (Invitrogen) transfection reagents according to
the manufacturer's protocol. The PMCA expression was conﬁrmed
by Western blot analysis. Samples were resolved on 7.5% acrylamide
gel following the procedure of Laemmli [45], with somemodiﬁcations
[21]. Proteins were subsequently transferred onto PVDF membranes
and the blots were immunostained with the anti-PMCA antibody 5F10.
2.4. Membrane preparation from COS-7 cells
Crudemicrosomal membranes were prepared as described previous-
ly [46]. Brieﬂy, cellswerewashed twicewith ice-cold phosphate-buffered
saline pH 7.4 and harvested in phosphate-buffered saline containing
0.1 mM AEBSF, 6 μg/ml aprotinin, 2.24 μg/ml leupeptin and 1 mM
EGTA pH 7.4. Cells were collected by centrifugation and resuspended
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pH 7.4, 0.96 mM MgC12, 4 μg/ml aprotinin, 2 μg/ml leupeptin, 4 mM
dithiothreitol (DTT) and 0.5 mM EGTA pH 7.4. After lysis cells were
diluted in a solution containing 10 mM Tris–HCl pH 7.4, 4 mM DTT,
4 μg/ml aprotinin, 2 μg/ml leupeptin, 0.5 M sucrose and 0.3 M KCl
and homogenized with a Dounce homogenizer. After centrifugation
2 mM EDTA was added to the supernatant and it was centrifuged at
100,000 g for 50 min. The pellet was resuspended in a solution of
0.25 M sucrose, 0.15 M KCl, 10 mM Tris–HCl, pH 7.4, 2 mM DTT and
20 μM CaCl2, and the membrane preparations were stored in liquid N2.
2.5. Ca2+ transport measurements
Ca2+ uptake by microsomal membrane vesicles was measured as
described previously [38,47]. The reaction mixture contained 25 mM
Tes/triethanolamine, pH 7.2, 100 mM KCl, 7 mM MgCl2, 90 μM EGTA,
100 μM CaCl2, labeled with 45Ca2+ (8.12 μM free Ca2+), 40 mM
KH2PO4/K2HPO4, pH 7.2, 200 nM thapsigargin, 4 μg/ml oligomycin
and occasionally 235 nM calmodulin. Ca2+ uptake of microsomes
was initiated by the addition of 5 mM ATP. The reaction was termi-
nated by rapid ﬁltration of the microsomes using Millipore membrane
ﬁlters (0.45 μm pore size). Data were analyzed with GraphPad Prism 4
(GraphPad Software Inc.)
2.6. Image acquisition and quantiﬁcation
HeLa, MDCKII and COS-7 cells were seeded into an eight-well
Nunc Lab-Tek II chambered coverglass (Nalge Nunc International,
No: 155411) at 5 × 104/well or 1 × 105/well cell density one day
prior to transfection. Then cells were transfected with the appropriate
plasmids and further grown for 48 h. For the internalization assay
cells were washed 2 times with Ca2+ free Hank's Buffered Salt Solu-
tion (HBSS) supplemented with 0.9 mM MgCl2, 100 μM EGTA,
100 μM CaCl2 and 20 mM Hepes (pH 7.4) and incubated in Ca2+
free HBSS for 1 h. HUVEC cells were seeded into gelatin-ﬁbronectin
coated eight-well chambered coverglass at either high or low density
and grown for 48 h to achieve the required conﬂuency, as indicated.
Cells were immunostained and analyzed by confocal microscopy. To
perform immunostaining for the localization studies, cells were gently
washed with phosphate-buffered saline (PBS), ﬁxed with 4% parafor-
maldehyde in PBS for 10 min, washed with PBS and permeabilized in
prechilled (−20 °C) methanol for 5 min at room temperature. Sam-
ples were blocked for 1 h at room temperature in PBS containing
2 mg/ml BSA, 1% ﬁsh gelatin, 0.1% Triton X-100 and 5% goat serum,
then incubated for 1 h at room temperature with primary antibody
diluted in blocking buffer. After washingwith PBS, cells were incubated
for 1 h at room temperature with Alexa Fluor conjugated secondary
antibody diluted 250× in blocking buffer. After three washes samples
were stained with 5 μg/ml WGA Alexa Fluor 633 conjugate (10 min at
room temperature). After repeated washes, samples were studied
with an Olympus IX-81/FV500 laser scanning confocal microscope,
using an Olympus PLAPO 60× (1.4) oil immersion objective (Olympus
Europa GmbH). Green, red and deep red ﬂuorescence was acquired at
505–535 nm, 580–620 nm and N660 nm, using excitations at 488,
543 and 633 nm laser lines, respectively. To obtain statistical analysis
of the localization experiments, cells were counted on the basis of
showing mostly plasma membrane or mostly intracellular PMCA local-
ization, as followed by PMCA co-localization with the appropriate com-
partment markers.
2.7. Ca2+ signal measurements
HeLa cells were seeded into a Nunc Lab-Tek II chambered coverglass
one day prior to transfection. The appropriate constructs (GCaMP2 and
mCh-PMCA4b) were co-transfected using FuGENE HD reagent as de-
scribed above. Before confocal imaging cells were switched to PhenolRed-free DMEM supplemented with 10% FBS, 10 mM HEPES (pH 7.4)
for 2 h. Store operated Ca2+ entry (SOCE) was measured based on the
“Ca2+ re-addition” protocol [48]. Intracellular Ca2+ stores were de-
pleted by 2 μM thapsigargin (Tg) combined with 10 μM histamine
in Ca2+ free Hank's Buffered Salt Solution (HBSS) supplemented
with 0.9 mM MgCl2 and 20 mM Tris (pH 7.4). SOCE was initiated
by the re-addition of CaCl2 to adjust external Ca2+ concentration to
2 mM. Images were taken with an Olympus IX-81 laser scanning
confocal microscope and Fluoview FV500 (v4.3) software using an
Olympus PLAPO 60× (1.4) oil immersion objective. For GCaMP2 im-
aging cells were excited at 488 nm and emission was collected be-
tween 505 and 535 nm. mCherry-tagged PMCA4b was illuminated
at 543 nm and emission above 560 nm was recorded. Images were
acquired every 0.3 s, z-resolution was 1 μm. Time-lapse sequences
were recorded with Fluoview Tiempo (v4.3) time course software at
room temperature. The relative ﬂuorescence was calculated as F/F0
(where F0 was the average initial ﬂuorescence). GraphPad Prism4
software (GraphPad Software Inc.) was used to analyze the experimen-
tal data.
2.8. Cell-surface biotinylation assay
For cell surface biotinylation studies, the Cell Surface Protein Isola-
tion Kit (Pierce, 89881) was used following the manufacturer's instruc-
tions with minor modiﬁcations. Transfected HeLa cells were washed
twice with ice-cold BupH™ PBS (pH 7.2). Cell-surface proteins were la-
beled by incubation with 0.25 mg/ml non-membrane-permeable
Sulfo-NHS-SS-biotin [sulfosuccinimidyl-2-(biotinamido) ethyl-1,3-
dithiopropionate] in PBS for 30 min on a rocking platform on ice.
Biotinylation was stopped by adding Quenching Solution. After the
labeling of the cell surface proteins with biotin, cells were washed and
collected as described below. Cells were scraped in PBS containing prote-
ase inhibitors (0.1 mM AEBSF, 10 μg/ml leupeptin, 20 μg/ml aprotinin),
sedimented by centrifugation and washed again with BupH™ TBS
(pH 7.2, Pierce). After centrifugation, cells were lysed in Lysis Buffer
containing protease inhibitors (0.1 mM AEBSF, 10 μg/ml leupeptin,
20 μg/ml aprotinin) for 30 min on ice. The cell extract was centrifuged
and one-tenth of the cell extract supernatant was solubilized in
Laemmli's buffer containing 100 mM freshly made dithiothreitol after
centrifugation (input fraction). The rest of supernatant was incubated
with Immobilized NeutrAvidin™ Gel for 60 min at room temperature
with end–over–end mixing using a rotator in order to precipitate
biotinylated proteins. Subsequently, the streptavidin beads were washed
ﬁve times with Wash Buffer and proteins were eluted from the beads
(bound fraction) with Laemmli's buffer containing 50 mM freshly made
No-Weigh™ dithiothreitol. The precipitates were resolved by SDS-PAGE
and transferred onto PVDF membrane, followed by Western blotting.
Immunoreactive bands were quantiﬁed by densitometric analysis using
the ImageJ 1.47d software (NIH Image, Bethesda, MD).
2.9. Data analysis and statistics
Data presented in Figs. 4 and 6 are means of at least three indepen-
dent experiments ± S.D. Statistical signiﬁcance for the biotinylation
assay was determined by Student's t-test. For statistical analysis of data
in Figs. 3 and 5 and in the Results section, cells were scored according
to the scoring system described in Supplementary Fig. 1 (n = number
of cells scored). Using this scoring system an investigator uninformed
of the experiment's goals scored the confocal images. Since the distribu-
tion (analyzed by χ2 test) was not statistically different from one exper-
iment to another, the data from individual experiments were pooled
for the statistical analysis. Statistical signiﬁcance of image scores was de-
termined by the χ2 test. For statistical analysis of data in the Results
section3.8, cellswere scored according to the distribution of the internal-
ized PMCA (punctuate or tubular-shaped structure) and the statistical
signiﬁcance was determined by the χ2 test. Statistical analyses were
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3. Results
3.1. Enhanced cell conﬂuency induces plasma membrane localization of
PMCA4b
To investigate the effect of the conﬂuency of cells on the localiza-
tion we transiently expressed PMCA4b in HeLa cells and studied the
distribution of the pump in non-conﬂuent and conﬂuent cell cul-
tures. At 48 h post-transfection cells were ﬁxed and co-stained
with anti-PMCA4 antibody JA9 and ﬂuorescent wheat germ agglutinin
(WGA) followed by confocal imaging (Fig. 1A). To obtain statistical
data of the localization experiments cells were scored for PMCA distri-
bution according to the ranking shown in Supplementary Fig. 1 similarly
as described previously [49]. A score of 1was given to a cell when PMCA
ﬂuorescence was almost exclusively detected at the plasmamembrane.
A score of 2 indicated strong plasma membrane staining with some
intracellular labeling; a score of 3 indicated weak plasma membraneFig. 1. Plasma membrane expression of PMCA4b is enhanced upon increasing density
of cells. A, HeLa cells were transfected with wild-type PMCA4b. 2 days after transfec-
tion cells were ﬁxed and stained with anti-PMCA4 antibody JA9. At the same time
the cells were also stained with Alexa-647 tagged wheat germ agglutinin (WGA) as a
plasma membrane marker (WGA labels both the plasma membrane and the Golgi
compartments). Representative confocal images of non-conﬂuent and conﬂuent cells
expressing PMCA4b. Scale bars, 20 μm. B, Localization of the endogenous PMCA4b in
non-conﬂuent and conﬂuent HUVEC cultures stained with anti-PMCA4b-speciﬁc antibody,
JA3. The left hand image shows staining with an isotype control antibody (mouse IgG1).
Confocal images were taken at the same acquisition parameters and settings. Scale bars,
20 μm.labeling and strong intracellular staining and a score of 4 indicated that
the PMCA ﬂuorescence was almost exclusively localized to the cytosol.
WGA staining was used as a marker of plasma membrane. In non-
conﬂuent cell cultures 21% of cells (n = 775) showed mostly plasma
membrane PMCA localization (scored 2 or 1) whereas in conﬂuent cell
cultures 75% of cells scored 2 or 1 (n = 323) (Fig. 1A and 3B). These
data show that conﬂuence of the cells resulted in a signiﬁcant difference
in the cellular distribution of PMCA4b (p b 0.0001, χ2 test).
To exclude overexpression artifacts, we performed the experi-
ments with cells expressing PMCA4b endogenously. For this purpose
we used primary endothelial cells isolated from human umbilical vein
(HUVECs) because these cells have been reported to express PMCA4b
[50] and can form a conﬂuent monolayer. Cells were seeded at differ-
ent initial densities to reach various stages of conﬂuence. After 2 days
in cultures, cells were ﬁxed and stained with the species-speciﬁc
anti-PMCA4b antibody JA3 and the plasma membrane marker WGA,
followed by confocal imaging. Fig. 1B shows speciﬁc PMCA4b staining
in these cells with a clearly different localization pattern depending on
cell density. An investigator uninformed of the experiment's goals
scored images (scores 1–2) of conﬂuent HUVEC layers signiﬁcantly
higher than that of non-conﬂuent cultures (p b 0.0001, χ2 test). Only
11% of non-conﬂuent cells (n = 171) showed mostly plasma mem-
brane localization (scored 1 or 2) while 76% of cells (n = 413) scored
2 or less in conﬂuent cultures (Fig. 3B). Our ﬁndings of an increased
PMCA4b protein delivery to the plasma membrane upon formation of
a conﬂuent cell layer conﬁrm previous observations on epithelial cell
lines [19,20].
3.2. Enhanced plasma membrane localization of PMCA4b in conﬂuent
HeLa cell culture enhances Ca2+ extrusion
To test whether the enhanced plasma membrane expression
of PMCA4b in conﬂuent culture inﬂuenced the Ca2+ extrusion, HeLa
cells were cotransfected with the ﬂuorescent calcium indicator,
GCaMP2 and mCherry-tagged PMCA4b. Confocal Ca2+ imaging was
performed on cells in subconﬂuent and conﬂuent cultures expressing
both the GCaMP2 and the PMCA4b constructs. We monitored the
store-operated Ca2+ entry (SOCE) signal after depleting the intracel-
lular Ca2+ stores. First, we emptied the endoplasmic reticulum (ER)
Ca2+ pool under Ca2+-free conditions with sequential additions of
thapsigargin, a SERCA pump inhibitor which prevents the reﬁlling of
ER pool and histamine that induces IP3-mediated Ca2+ release from
the ER. After intracellular Ca2+ store depletion, external Ca2+ was re-
stored to 2 mM and the SOCE signal was followed for 5 min by confo-
cal imaging of GCaMP2 ﬂuorescence. Fig. 2B and C shows the SOCE
signals in subconﬂuent and conﬂuent HeLa cells expressing mCherry-
PMCA4b. In subconﬂuent culture most cells exhibited a prolonged
decay phase of the SOCE-induced Ca2+ transients compared to the rel-
atively fast decay in the PMCA4b expressing conﬂuent cell cultures. To
quantitatively assess these results we calculated the areas under the
peaks of the Ca2+ signals (Fig. 2D). In conﬂuent cell cultures a signiﬁ-
cantly lower Ca2+ peak area was observed than in cells in subconﬂuent
cultures (p b 0.001, Student's t-test). Our results show that conﬂuency-
mediated upregulation of PMCA4b expression in the plasmamembrane
improves the Ca2+ extrusion property of HeLa cells.
3.3. C-terminal truncation revealed a localization signal between residues
Lys1158 and Asn1181 of PMCA4b
Further, we studied the localization of the PMCA4b pump with
the help of previously established C-terminally truncated mutants
PMCA4b-ct24, -ct48 and -ct57 [37,39,47]. The C-terminal sequences
of all truncated constructs are shown in Fig. 4A. The distributions of
the truncated pumps in non-conﬂuent or conﬂuent HeLa cells were
analyzed by immunoﬂuorescence using monoclonal anti-PMCA4 an-
tibody JA9 that recognizes the N-terminal region of PMCA4 between
Fig. 2. Enhanced plasma membrane expression of PMCA4b in conﬂuent cell culture increases the Ca2+ extrusion. HeLa cells were transfected with mCherry-PMCA4b and the ﬂuo-
rescent Ca2+ sensor, GCaMP2. Changes in intracellular Ca2+ concentration were measured by confocal imaging of GCaMP2. Ca2+ imaging was performed on cells in subconﬂuent
and conﬂuent cultures. SOCE mediated Ca2+ transients were evoked as described in the Materials and methods section. A, Representative confocal images of HeLa cells expressing
mCherry-PMCA4b in subconﬂuent (A1) and conﬂuent cultures (A2). B, SOCE induced Ca2+ transients in HeLa cells expressing mCherry-PMCA4b in subconﬂuent (B1) and conﬂuent
cultures (B2). C, Averaged Ca2+ signals from cells in subconﬂuent cultures (black curve) and in conﬂuent cultures (red curve) from 3 independent experiments. Curves show the
means ± 95% CI. B and C, Normalized values (F/F0) of SOCE induced transients. D, Peak areas of Ca2+ signals (arbitrary units). Data are means ± S.D. Asterisks (***) denote signif-
icant difference between the peak areas of signals in conﬂuent and subconﬂuent cell cultures (p b 0.0001, Student's t-test). Data are from n = 34 cells in subconﬂuent cultures and
from n = 23 cells in conﬂuent cultures from 3 independent experiments.
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not interfere with JA9 immunoreactivity. In non-conﬂuent HeLa cells
we found enhanced plasma membrane localization of PMCA4b-ct48
and ct57 mutants when compared to the wild type PMCA4b, but little
if any plasma membrane localization could be detected in the case of
PMCA4b-ct24 that was retained fully in intracellular compartments
even in conﬂuent cultures (Fig. 3). The complex localization pattern of
the truncated mutants raised the possibility for the presence of a func-
tional C-terminal localization determinant that could mediate targeting
of the PMCA4b to the plasma membrane.
3.4. Site-directed mutagenesis of the putative di-leucine motifs
in PMCA4b
Based on our ﬁnding that the PMCA4b-ct24 mutant was retained
in the intracellular region of the cell while PMCA4b-ct48 was deliveredto the plasma membrane (Fig. 3), we hypothesized that the region be-
tween the C-terminus of PMCA4b-ct24 (Asn1181) and the C-terminus of
PMCA4b-ct48 (Asp1157) serves as a localization signal for the PMCA4b
isoform. Closer inspection of the corresponding sequence revealed a
di-leucine motif 1167LLL within the 1158Lys-Asn1181 region and another
one – 1147LL – somewhatmore upstream (Fig. 4A). In order to investigate
if the di-leucine motifs were critical for the the plasma membrane
expression of PMCA4b we generated 1) single di-leucine mutants
L1147–48A and L1167–69A in which all leucine residues in one of the
two di-leucine motifs were replaced by alanines; and 2) double
di-leucine mutants L1147–48A/L1167–69A in which all leucine residues in
both di-leucine motifs were mutated simultaneously in the wild-type
PMCA4b or in the truncated PMCA4b-ct24. Bold letters in Fig. 4A show
where these mutations were. To test the expression of the constructs
the wild-type and mutated PMCA proteins were transiently expressed
in COS-7 cells and microsomes were prepared at 48 h post-transfection
Fig. 3. Plasma membrane expression of PMCA4b is modulated by the C-tail. A, Confocal
images of conﬂuent HeLa cells expressing the C-terminally truncated PMCA4b mutants
(PMCA4b-ct24, PMCA4b-ct48 and PMCA-ct57). Cells were stained with anti-PMCA4
antibody JA9. Scale bars, 20 μm. B, Frequency of cells showing mostly plasma mem-
brane localization (scores 1–2) of wild type PMCA4b and C-terminally truncated
PMCA4b mutants expressed in HeLa cells as compared to the endogenous PMCA4b in
HUVECs. Plasma membrane localization of PMCAs in non-conﬂuent (white columns)
or conﬂuent (gray columns) was identiﬁed by their co-localization with the plasma
membrane marker WGA and quantiﬁed using the scoring system described in Supple-
mentary Fig. 1. 5 independent experiments were performed (at least 300 cells were
counted for each condition (except for non-conﬂuent HUVECs (n = 171))) and the
pooled data were analyzed using the Chi-square test. Asterisks (***) denote a signiﬁ-
cant difference when compared to PMCA4b in non-conﬂuent cells (ﬁrst white column)
(p b 0.0001, χ2 test). Number signs (###) represent signiﬁcant differences between
conﬂuent and non-conﬂuent HeLa and HUVEC cultures (p b 0.0001, χ2 test). Plus signs
(+++) denote signiﬁcant differences between PMCA4b and PMCA4b-ct24 expressing
HeLa cells grown to conﬂuence.
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the microsomes showed similar expression level of the proteins
(the L1147–48A mutants are not shown) as judged by the intensity of
the antibody staining. The differences in the molecular masses be-
tween the wild-type PMCA4b and mutant proteins are also evident
in Fig. 4B. ATP-dependent Ca2+ uptake measurements of microsome
preparations provided evidence that apart from the PMCA4b-ct24
mutant the truncated proteins and the L1167–69A substitution mutants
were fully functional and the calmodulin-responsiveness for all con-
structs was also retained (Fig. 4C). Notably, the truncated PMCA4b-ct24
mutant showed a relatively low Ca2+ transport activity in correlation
with its full retention in intracellular compartments. Mutation of the
1167LLL motif partially rescued this protein from these compartments
resulting in noticeable plasma membrane orientation and enhanced
Ca2+ transport activity (Fig. 4C and D).
3.5. The di-leucine motif 1167LLL is a plasma membrane localization
signal in PMCA4b
The enhanced plasma membrane localization and Ca2+ transport
activity of the PMCA4b-ct24-L1167–69A mutant in COS-7 cells suggested
that the 1167LLL motif operated as a localization signal for the pump. To
understand more the trafﬁcking properties of the PMCA4b both wild
type and mutant pumps were expressed in HeLa cells and their cellulardistribution was further studied in non-conﬂuent cultures (Fig. 5). In
contrast to the mixed plasma membrane/intracellular localization of
the wild type PMCA4b (upper left panel), the PMCA4b-L1167–69A mutant
was concentrated mainly in the plasma membrane (lower left panel).
The effect of the L1167–69A substitution in the PMCA4b-ct24 truncated
protein was even more pronounced; while PMCA4b-ct24 was detected
exclusively in intracellular compartments (upper right panel), the
PMCA4b-ct24-L1167–69A mutant showed signiﬁcant plasma membrane
localization (lower right panel).
As discussed above an additional di-leucine motif (1147LL) was lo-
cated upstream of the 1167LLL of PMCA4b that could be part of a com-
plex hydrophobic recognition signal for cellular sorting elements.
Thus, we studied the role of 1147LL in the plasma membrane targeting
of the PMCA4b pump. We found that mutating the leucines in the
1147LL motif did not affect cellular distribution of the wild type pump
but enhanced the plasma membrane expression of the PMCA4b-ct24
truncated mutant (Fig. 5A middle panels and B). Plasma membrane
expression was not increased any further by mutating both di-leucine
motifs. These data suggest that 1147LL is exposed only by C-terminal
truncation of the last 24 residues in the PMCA-ct24 mutant and that
1167LLL is the major localization determinant in PMCA4b.
Next we biochemically quantiﬁed the relative abundance of PMCA
proteins on the cell surface of HeLa cells expressing C-terminally
truncated and L1167–69A substituted PMCA mutants. Plasma mem-
brane expression of wild-type and mutated PMCA4b proteins was de-
termined by cell-surface biotinylation using the Cell Surface Protein
Isolation Kit (Pierce). Fig. 6 shows immunoblots of the biotinylated
fraction (indicative of plasma membrane expression) as compared
to 10% of the total proteins of each sample probed by the monoclonal
anti-PMCA antibody 5F10. Immunoreactive bands were quantiﬁed by
densitometric scanning and percentage of the biotinylated fraction
relative to the total PMCA proteins was expressed and shown in
the bar graph of Fig. 6. A relatively small fraction of the wild-type
PMCA4b was biotinylated (b15%) supporting its partial intracellular
localization. The C-terminally truncated PMCA4b-ct24 mutant was
also poorly biotinylated (b10%) whereas the biotinylated fraction of
the other truncated mutants PMCA4b-ct48 and -ct57 was signiﬁcant-
ly increased indicating a substantially enhanced plasma membrane
expression of the pumps lacking the 1167LLL motif. Furthermore the
L1167–69A mutation resulted in almost a two-fold increase in the abun-
dance of proteins in the biotinylated fraction of both wild type and
ct24 pumps. These results are consistent with the ﬁndings of the confo-
cal microscopy study showing that the 1167LLL motif plays an important
role in surface expression of the PMCA4b isoform in HeLa cells.
3.6. The 1167LLL motif is not required for basolateral targeting of PMCA4b
In a previous study we showed that a mutation removing the up-
stream di-leucine 1147LL motif did not affect basolateral sorting of
PMCA4b in polarized MDCK cells [11]. To test the impact of the
1167LLL motif on basolateral targeting, we compared the subcellular lo-
calization of the substitution mutant L1167–69A and wild-type PMCA4b
in a polarized MDCKII cell monolayer and showed that both proteins
were delivered correctly to the basolateral membrane together with
the basolateral plasma membrane marker Na/K ATPase (Fig. 7). These
results clearly showed that similarly to the 1147LL motif, the 1167LLL
di-leucine motif was also not required for the basolateral targeting of
the PMCA4b pump in polarized MDCK cells.
3.7. Dynamin-dependent endocytosis is involved in the trafﬁcking of
PMCA4b
One key component of membrane trafﬁcking in animal cells is the
large GTPase dynamin that acts as a membrane scissor of endocytic
vesicle formation [51]. The dominant negative (K44A) mutant of
dynamin, an inhibitor of endocytic vesicle formation, is often used to
Fig. 4.Mutations of the di-leucine motifs in the C-tail of PMCA4b. A, Mutation of the C-tails of PMCA4b and its C-terminally truncated PMCA4b-ct24 mutant. The underlined leucine
residues were replaced by alanines in both the full-length PMCA4b and its truncated mutant (bold, underlined). The C-terminal sequences of two additional truncated PMCA4b
mutants (ct48 and ct57) are also shown. B, Expression of PMCA4b and its mutants in COS-7 cells was assessed by immunoblot. Microsomal membrane preparations were isolated
from COS-7 cells transiently transfected with the appropriate PMCA constructs. 0.5 μg of each sample was immunoblotted with anti-PMCA antibody 5F10. C, Ca2+ transport activities of
PMCAswere determined by Ca2+ uptake bymicrosomes prepared from COS-7 cells expressing PMCA4b or itsmutants. Ca2+ uptakemeasurementswere carried out in the presence (gray
columns) or in the absence (white columns) of calmodulin.Meanvalues ± S.D. obtained from three independent experiments are plotted. Asterisks denote signiﬁcant difference between
the activities of PMCA4b-ct24 and its PMCA4b-ct24L1167–69A mutants in the presence of calmodulin (** p b 0.01, Student's test). D, Subcellular distribution of PMCA4b-ct24 or
PMCA4b-ct24L1167–69A mutants expressed in COS-7 cells. After two days transfection cells were ﬁxed and stained with anti-PMCA antibody 5F10 and ﬂuorescently labeled secondary
antibody. Arrowheads indicate plasma membrane localization of the PMCA4b-ct24L1167–69A mutant. Scale bar, 10 μm.
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[52–54]. To study the role of dynamin in the trafﬁcking of PMCA,
we tested if dynamin K44A affected the localization pattern of the
PMCA4b-ct24 mutant that was found mostly in intracellular compart-
ments when expressed alone. Hence, PMCA4b-ct24 was co-expressed
with wild type dynamin or with the K44A mutant and cells were
analyzed by immunoﬂuorescence using anti-PMCA4 (5F10) and
anti-dynamin (anti-dyn2) antibodies, respectively (Fig. 8). When
the PMCA4b-ct24 truncated pump was co-expressed with wild type
dynamin it showed distinct intracellular localization (upper panels).
However, when co-expressed PMCA4b-ct24 with the dominant nega-
tive dynamin K44A mutant a clear ﬂuorescent signal of PMCA4b-ct24
could be detected at the cell periphery. The frequency of cells scored 3
or less (see Supplementary Fig. 1) was low (8.3%) in cells coexpressing
the PMCA4b-ct24with thewild-type dynamin (n = 96),while the pro-
portion of cells with PMCA at the plasma membrane (64.6%) increased
signiﬁcantly in the HeLa cells co-expressing the PMCA4b-ct24 with the
dynamin K44Amutant (n = 48) (p b 0.0001, χ2 test, data were pooled
from 3 independent experiments). These data suggest that dynamin-
dependent endocytosis is involved in the trafﬁcking of PMCA4b.
3.8. Internalization of PMCA4b is affected by the mutation of 1167LLL motif
Our experiments showed that for efﬁcient plasmamembranedelivery
of PMCA4b, cells needed to reach conﬂuency. Based on these data weassumed that disruption of cell–cell contacts induced internalization of
the PMCA4b pump. Extracellular calcium removal is a commonly used
technique to disrupt cell–cell contact for studying cadherin endocytosis
[55]. Therefore, to examine the trafﬁcking of PMCA4b from the plasma
membrane to intracellular organelles we expressed wild type PMCA4b
and PMCA4b-L1167–69A mutant in HeLa cells and on day 2 after transfec-
tion cell–cell adhesion was disrupted by removal of extracellular Ca2+.
After 1 h treatment with Ca2+-free medium cells were ﬁxed and stained
with anti-PMCA4 antibody JA9 and anti-pan-cadherin antibody and the
localization of cadherin and PMCA was monitored, simultaneously. We
used cadherin as a marker for studying PMCA internalization because
the route of cadherin endocytosis is well characterized [56,57]. Upon
Ca2+ depletion both thewild-type PMCA4b and its L1167–69Amutant in-
ternalized into cytosolic compartments, however, the distribution of
the internalized wild-type and mutant proteins differed considerably
from one another (Fig. 9). Staining of the wild-type PMCA4b revealed
punctate structures concentrated in the perinuclear regions similarly
to the distribution of cadherin. In contrast, the PMCA4b-L1167–69A mu-
tant associated with long tubular-shaped structures within the cytosol
of many cells. The frequency of such cells was low (3.2%) in HeLa cells
expressing the wild type PMCA4b (n = 155). In contrast, the propor-
tion of cells containing tubular-shaped structures was signiﬁcantly
higher (28.9%) in the HeLa cells expressing the PMCA4b-L1167–69A mu-
tant (n = 201) (p b 0.0001, χ2 test, data were pooled from 3 indepen-
dent experiments).
Fig. 5. Subcellular distribution of PMCA4b, PMCA4b-ct24 and their di-leucine mutants in HeLa cells. A, HeLa cells were transfected with wild type PMCA4b, C-terminally truncated
PMCA4b-ct24 and their L1167–69A and L1147–48A substitution mutants. Two days after transfection, cells were ﬁxed and stained with anti-PMCA antibody 5F10. The effect of the mu-
tations on the localization of the pump was studied in non-conﬂuent cultures. Scale bar, 10 μm. B, Frequency of cells showing mostly plasma membrane localization (scores 1–2) of
PMCA4b and its mutants in non-conﬂuent HeLa cell culture. Plasma membrane localization of PMCAs was identiﬁed by their co-localization with the plasma membrane marker
WGA and quantiﬁed using the scoring system described in Supplementary Fig. 1. 5 independent experiments were performed (at least 300 cells were counted for each condition
(except the double di-leucine mutants (n = 75))) and the pooled data were analyzed using the Chi-square test. Asterisks (***) denote signiﬁcant differences compared to PMCA4b
(p b 0.0001, χ2 test). Number signs (###) represent signiﬁcant differences compared to PMCA4b-ct24 (p b 0.0001, χ2 test).
Fig. 6. Mutation of di-leucine motif at positions 1167–69 results in increased surface
expression of PMCA4b and PMCA4b-ct24. Plasma membrane localization of PMCA4b
and its di-leucine mutants was quantiﬁed by cell-surface biotinylation. Top, PMCA4b,
C-terminally truncated and L1167–69A mutants were expressed in HeLa cells. Two
days after transfection surface membrane protein was labeled with biotin then isolated
using streptavidin. Biotinylated surface proteins and 10% of total fraction were re-
solved by SDS-PAGE and PMCA proteins were detected by Western blotting. Blots
were stained with anti-PMCA antibody 5F10. Bottom, Signals were quantiﬁed by den-
sitometric analysis using the ImageJ software (NIH Image, Bethesda, MD) and the
biotinylated fraction (surface PMCA expression) was calculated as a percentage of
total PMCA expression. Values represent means ± S.D. Data were obtained from 3 in-
dependent experiments. Signiﬁcant differences are marked with asterisks: **p b 0.01,
***p b 0.0001, Student's t-test.
Fig. 7. Subcellular localization of GFP-PMCA4b and GFP-PMCA4b-L1167–69A in polarized
MDCK monolayer. GFP-PMCA4b and GFP-PMCA4b-L1167–69A were expressed in polar-
ized MDCK cells. The expressed PMCA proteins were detected by GFP ﬂuorescence
(green). Na+/K+-ATPase, a marker protein of the basolateral plasma membrane was
labeled using anti-Na+/K+-ATPase antibody and ﬂuorescence-labeled secondary anti-
body (red). X–y scans and x–z scans were obtained using confocal microscopy. Note
that the PMCA4b-L1167–69A mutant localized at the basolateral membrane similarly
to the wild-type PMCA4b. Scale bars, 10 μm.
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Fig. 8. Subcellular localization of PMCA4b-ct24 co-expressed with wild-type dynamin
or the K44A dynamin mutant. HeLa cells co-expressing PMCA4b-ct24 mutant (green)
with wild-type dynamin (red) or with the dominant-negative K44A dynamin mutant
(red) were ﬁxed and stained with antibodies recognizing PMCA (5F10) or dynamin
(anti-dyn2). Note that PMCA4b-ct24 co-expressedwith wild-type dynamin is exclusively
localized in the cytosol (upper panel) while PMCA4b-ct24 co-expressed with inactive
dynamin K44Amutant is also found in the plasmamembrane as indicated by arrowheads
on the lower left panel. Scale bars, 10 μm.
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endosomal compartments
Our results suggested that wild-type PMCA4b internalized to early
endosomes possibly using similar pathways as cadherins [56–58].
Therefore, we tested whether the PMCA-positive intracellular vesicles
co-localized with the early endosome marker, EEA1 (early endosome
antigen 1) [59]. HeLa cells were transfected with wild-type PMCA4b,
PMCA4b-L1167–69A mutant or the C-terminally truncated PMCA4b-ct57
pump. After 2 days of transfection, cells were incubated with Ca2+-free
medium for 1 h as above and co-stainedwith anti-PMCA4 antibody JA9,
anti-EEA1 antibody and ﬂuorescent wheat germ agglutinin (WGA).
The PMCA-positive vesicles were detected near the Golgi region
(WGA-positive region) and co-localized partially with the early
endosomal marker (Fig. 10, inset, arrows). In the case of the PMCA4b-
ct57 mutant long tubular structures were observed similarly to those
seen in the L1167–69A mutant-expressing cells. The relative frequency of
PMCA4b-ct57 expressing cells containing tubular structures was 31.5%
(n = 168) that is signiﬁcantly higher compared to cells expressing the
wild-type PMCA4b (p b 0.0001, χ2 test). No co-localizationwas detected
between the mutant (L1167–69A or ct57) PMCA-positive structures and
the early endosome marker. These results suggest that PMCA4b can
pass through the early endosomal compartment but eliminating of the
1167LLL motif either by mutation or by truncation prevents the pump
from entering this compartment.
4. Discussion
In this study we showed that surface expression of PMCA4b de-
pends on the degree of conﬂuency in cultured epithelial (HeLa) cells
or endothelial (HUVEC) cells. In conﬂuent cells PMCA4b localizedmost-
ly in the plasma membrane, as expected while in non-conﬂuent cells itshowed a low level of plasmamembrane expression. A similar behavior
of the PMCA4b pump has been reported in colon and distal convoluted
tubule cells [19,20]. In good correlationwith the localization studies our
SOCE mediated Ca2+ signaling experiments showed substantially im-
proved Ca2+ clearance from conﬂuent cells compared to subconﬂuent
cultures.
Truncation and substitution mutations revealed that plasma mem-
brane expression of the pump is tightly controlled by the C-terminal
tail. We found two di-leucine-like motifs in the C-tail of PMCA4b: one
of those di-leucine motifs (1167LLL) served as an internalization signal
and was responsible for the intracellular targeting of the full-length
pump in non-conﬂuent cells. In conﬂuent (non-migrating) cells the
1167LLL internalization signal is probably masked by a yet unidentiﬁed
protein partner that rescues PMCA4b to the plasma membrane.
Masking of di-leucinemotifs by protein partners is awidely usedmech-
anism to regulate plasma membrane expression of several membrane
proteins with different functions. In conﬂuent cells the di-leucine inter-
nalization signal of cadherin is masked by p120-catenin, preventing
cadherin from internalization [60]. Other examples are the R2 subunit
of γ-aminobutyric acid type B (GABAB) receptor which regulates the
surface stability of the GABAB receptor by masking a di-leucine motif
on its R1a subunit [61] and the T cell receptor (TCR) complex where
the CD3γ chainmasks the endocytosismotif in CD3γ subunit and stabi-
lizes TCR cell surface expression [62].
Cadherins can be internalized both via clathrin-dependent and
clathrin-independent pathways mostly mediated by dynamin
[56,57,63]. Investigating the internalization routes of the different
PMCA constructs upon loss of cell–cell contact we found that full-length
PMCA4b trafﬁcked similarly to the cadherins through a dynamin-
dependent endosomal pathway. In contrast, mutation of the 1167LLL
motif prevented the pump from entering the early endosomes in-
stead the mutant pump concentrated more on tubular structures
connected to the plasma membrane. These data suggest that the 1167LLL
motif of PMCA4b is needed for entering the early endosomal compart-
ment which is essentially involved in further sorting.
We observed that the C-terminal region downstream of the
di-leucine motifs also remarkably inﬂuenced the surface expression
of the pump. Removing this sequence (PMCA4b-ct24 mutant) signif-
icantly decreased the amount of PMCA in the plasma membrane both
in non-conﬂuent and conﬂuent cells suggesting that this 24-residue
downstream region masks the internalization signal(s) either by itself
or by the help of other factors that interact and/or interfere with
the C-terminal localization determinants. The latter possibility is sup-
ported by the fact that the PMCA4b-ct24 mutant lacks the C-terminal
PDZ-binding sequence and thus, the ability to interact with PDZ-domain
proteins which can inﬂuence the plasma membrane stability of the
pump [21].
Moreover, replacing an upstream di-leucine motif, 1147LL in the
PMCA4b-ct24 mutant signiﬁcantly increased the plasma membrane
level of the truncated mutant although this replacement did not
change the localization of the full-length PMCA4b. These data suggest
that C-terminal truncation exposed the upstream di-leucine motif
1147LL in the C-tail of PMCA4b (which is normally hidden in the
wild type pump) hence both di-leucine signals 1147LL and 1167LLL
could be involved in the enhanced trafﬁcking of the PMCA4b-ct24
into intracellular compartments. Removal of only the downstream
di-leucine motif by further truncation (PMCA4b-ct48) resulted in en-
hanced plasma membrane expression also suggesting that 1167LLL is
the major determinant of PMCA4b targeting. Multiple di-leucine mo-
tifs mediating protein transport are also found in other transport pro-
teins such as “transmembrane protein 192” (TMEM192), mucolipin-1
or Na–K–2Cl co-transporter (NKCC2) [64–66].
Sequence alignments of human PMCA isoforms revealed that the
region containing the di-leucine pairs of PMCA4b and the corre-
sponding regions of other PMCA isoforms differ greatly fromone another
(Fig. 11A). The 1167LLL motif responsible for the targeting of full-length
Fig. 9. Internalization of PMCA4b and L1167–69A mutant after extracellular Ca2+ depletion. PMCA4b and PMCA4b-L1167–69A were expressed in HeLa cells. 2 days after transfection
cell–cell adhesion was disrupted by removal of extracellular Ca2+. After 1 h Ca2+ depletion cells were ﬁxed and stained with anti-PMCA4 antibody, JA9 (green) and
anti-pan-cadherin (red). Insets: higher magniﬁcation images of the areas within the white rectangles. Note that in the case of the wild-type PMCA4b punctate structures were
observed in the perinuclear regions similarly to the internalized cadherins, while in the case of the L1167–69A mutant long tubular-shaped structures were formed in the cytosol.
Scale bars, 10 μm.
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whereas the other di-leucine (or leucine-isoleucine) motif (LL/I) (the
1147LL motif in PMCA4b) is present in all “b” splice variants. It is possible
that in the isoforms PMCA1–3 the upstream LL/I motif is sufﬁcient for the
targeting/trafﬁcking control of the pumps. Indeed, previous experiments
demonstrated that the LL/I motif was necessary for basolateral targeting
of PMCA1b and PMCA2b [67] but not for PMCA4b [11]. Our data showed
that neither di-leucine motif was necessary for basolateral targeting of
PMCA4b.
Analysis of the sequences around the di-leucine motifs in PMCA4b
revealed a high degree of similarity of the surroundings of residues
1147LL and 1167LLL (the identical residues surrounding the di-leucine
motifs – 1147LL and 1167LLL – are marked with clear boxes in Fig. 11B,
upper sequence for H. sapiens). The RXXLLDXE motif that is repeated
twice within the region does not exhibit similarity to classical di-leucine
motifs ((E/D)XXXL(L/I)) [34] but resemble an atypical di-leucine motif
(LLXXEE) ﬁrst identiﬁed in K+/Cl− cotransporter KCC2 [33]. Moreover,
in KCC2 an arginine (R) residue is located at position −3 relative to
the ﬁrst leucine (RXXLLXXEE) similarly to the di-leucine-like motifs of
PMCA4b.
Sequence alignment of the di-leucine motifs of the human PMCA4b
with the same regions from other vertebrates revealed that the
di-leucine motifs are not conserved between species (Fig. 11B). Theexamined mammalian species (except rats) contain at least one of
these di-leucine signals. Introducing these localization signals during
the evolution of higher mammals gives an extraordinary advantage
for control of PMCA4b localization and activity in cells where PMCA4b
is most abundant such as the epithelium of the kidney, colon and breast
or cardiomyocytes.
In addition to the many regulatory mechanisms of PMCAs
(calmodulin, proteolysis, acidic phospholipids, phosphorylation etc.)
another way of regulating its activity is to control its concentration in
the plasma membrane. In a previous study we demonstrated that the
PDZ protein PSD95 retained PMCA4b in the plasma membrane and
hence increased its cell surface expression [21]. Here we show that,
apart from the PDZ interaction, cell surface expression of PMCA4b is
also mediated by a C-terminal endocytic motif. Removal of this motif
by mutation enhanced the plasma membrane expression of the pump
indicating that the di-leucine and the PDZ-bindingmotifs canmodulate
localization independent from one another.
In summary, at the C-terminus of PMCA4b we found a complex
regulatory unit that mediates the balance between the forward trafﬁck-
ing to the cell surface and the internalization of the pump, adjusting the
surface expression to the actual needs of the cells. We show that this
regulatory mechanism depends on the conﬂuency of cells, resulting
in great differences between the distribution of PMCA in conﬂuent
Fig. 10. Internalized PMCA4bmutantsmissing the di-leucinemotif 1167LLL does not localize to early endosomes. Confocal images of HeLa cells expressed PMCA4b, PMCA4b-L1167–69A and
C-terminally truncated ct57mutants treated by extracellular Ca2+ depletion for 1 h. Cellswere immunostainedwith anti-PMCA4 antibody, JA9 (green), antibody to early endosomemark-
er, EEA1 (red) and Golgi markerWGA (blue). Co-localization of PMCAs and early endosomes is shown in the merged images (yellow). Insets: higher magniﬁcation of the areas within the
white rectangles. Note that partial co-localization were observed between the PMCA and EEA1 signal in the case of wild-type PMCA4b (upper panel, arrows indicate the co-localized
vesicles in the inset). No co-localization was detected in the case of internalized PMCA4b mutants missing the di-leucine motif 1167LLL (middle and lower panels). Scale bars, 10 μm.
2571G. Antalffy et al. / Biochimica et Biophysica Acta 1833 (2013) 2561–2572(non-migrating) and non-conﬂuent cell cultures. Changes in the locali-
zation of the pump can change substantially the Ca2+ clearance of cells
after stimuli that should have a great impact on downstream signaling
events determining the cells fate and function.Fig. 11. Amino acid sequence alignment of the human PMCA isoforms and human PMCA4
with its orthologs.A, Alignment of amino acid sequences around twoputative di-leucinemo-
tifs (highligthed in gray) of human PMCA isoforms. B, Sequence alignment of PMCA4
orthologs. Identical residues around the di-leucine pairs are marked with clear boxes
(RxxLLDxxE). Amino acid sequenceswere obtained from theNational Center for Biotechnol-
ogy Information (NCBI)HomoloGene database and theUniversal Protein Resource (UniProt)
database. Amino acid sequences were compared with the NCBI Nucleotide Blast software.Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2013.06.021.Acknowledgements
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